Systematic Review The Activity Bitter Melon (Momordica Charantia L.) Against Molecular Targets Antidiabetic.
Abstract
Diabetes mellitus (DM) is a chronic disease that occurs either when the pancreas does not produce enough insulin, or when the body cannot effectively use the insulin it produces. The purpose activity of bitter melon fruit against molecular targets antidiabetic in literatre review.
Analysis and systematic web search reviews were carried out on the research literature related to bitter melon which is used for DPP4, PTP1B, α-glucosidase, and increasing GLUT4 levels. The data were collected from several journals with inclusion criteria. The data were extracted and synthesized.
The charantin, cucurbitacin, dan momordicoside D compound from bitter melon fruit has activating the TGR5 and GLP1 receptor simultaneously inhibiting DPP4. The cucurbitane 25-O-methylkaraviagein D the of bitter melon fruit has inhibitory activity against the PTP1B enzyme which is associated with the presence of –OH, The 3β,7β,25-trihydroxycucurbita-5,23(E)-dien-19-al, charantal, charantoside XI, dan 25ξ- isopropenylchole-5, 6-ene-3-O- D-glukopiranosida α-glucosidase predicted to have inhibitory activity of binding to the active side of the protein. The vicine, polypeptide-p, 5-,19-epoxy-3-, 25-dihydroxycucurbita-6,23 (E) -diene dan 3-7-,25-trihydroxycucurbita-5,23 (E)-dien-19-al can increase the amount of GLUT4 on the cell surface.
References
[2]. Ekayanti, Meiliza, Rani Sauriasari, and Berna Elya. 2018. “Dipeptidyl Peptidase IV Inhibitory Activity of Fraction from White Tea Ethanolic Extract (Camellia Sinensis (L.) Kuntze) Ex Vivo.” Pharmacognosy Journal 10(1): 190–93.
[3]. Gisela Wilcox. 2005. “Insulin and Insulin Resistance Gisela.” Insulin and Insulin Resistance Gisela 22(2): 61–63.
[4]. Hiem, Nguyen Xuan N et al. 2010. “A -Glucosidase Inhibition Properties of Cucurbitane-Type Triterpene Glycosides from the Fruits of Momordica Charantia.” 58(5): 720–24.
[5]. Kartini, Ketut, I Swantara, and I Suartha. 2015. “Isolasi Dan Identifikasi Senyawa Aktif Ekstrak Etanol Buah Pare (Momordica Charantia L.) Yang Dapat Menurunkan Kadar Glukosa Darah.” CAKRA KIMIA (Indonesian E-Journal of Applied Chemistry) 3(2): 32–38.
[6]. Kerru, Nagaraju, Ashona Singh-Pillay, Paul Awolade, and Parvesh Singh. 2018. “Current Anti-Diabetic Agents and Their Molecular Targets: A Review.” European Journal of Medicinal Chemistry 152(May): 436–88.
[7]. Kumar, Ramadhar, S Balaji, T S Uma, and P K Sehgal. 2009. “Fruit Extracts of Momordica Charantia Potentiate Glucose Uptake and Up-Regulate Glut-4 , PPAR ␥ and PI3K.” 126: 533–37.
[8]. Nobre, Cristiane P., Fernanda N. Raffin, and Túlio F. Moura. 2005. “Standardization of Extracts from Momordica Charantia L. (Cucurbitaceae) by Total Flavonoids Content Determination.” Acta Farmaceutica Bonaerense 24(4): 562–66.
[9]. Olalekan, Olusola et al. 2018. “Pathophysiology Potential Use of Bitter Melon ( Momordica Charantia ) Derived Compounds as Antidiabetics : In Silico and in Vivo Studies.” Pathophysiology 25(4): 327–33. https://doi.org/10.1016/j.pathophys.2018.05.003.
[10]. Poovitha, Sundar, and Madasamy Parani. 2016. “In Vitro and in Vivo α-Amylase and α-Glucosidase Inhibiting Activities of the Protein Extracts from Two Varieties of Bitter Gourd (Momordica Charantia L.).” BMC Complementary and Alternative Medicine 16(Suppl 1): 1–8. http://dx.doi.org/10.1186/s12906-016-1085-1.
[11]. Saifudin, Azis, Shigetoshi Kadota, and Yasuhiro Tezuka. 2012. “Protein Tyrosine Phosphatase 1B Inhibitory Activity of Indonesian Herbal Medicines and Constituents of Cinnamomum Burmannii and Zingiber Aromaticum.” Journal of Natural Medicines 67(2): 264–70.
[12]. Schwinghammer, Terry L. 2015. Pharmacotherapy Handbook Chapter 10. Hypertension.
[13]. Shih, Chun-ching, Cheng-hsiu Lin, Wei-li Lin, and Jin-bin Wu. 2009. “Momordica Charantia Extract on Insulin Resistance and the Skeletal Muscle GLUT4 Protein in Fructose-Fed Rats.” 123: 82–90.
[14]. Shivanagoudra, Siddanagouda R et al. 2019. “Bioorganic Chemistry Antidiabetic , Anti-Inflammatory Activities and in Silico Modeling Approaches.” Bioorganic Chemistry 87(January): 31–42. https://doi.org/10.1016/j.bioorg.2019.02.040.
[15]. Singh, Anand Krishna, Rameshwar Jatwa, and J A Y A Joshi. 2014. “CYTOPROTECTIVE AND DIPEPTIDYL PEPTIDASE IV ( DPP-IV / CD26 ) INHIBITORY ROLES OF OCIMUM SANCTUM AND MOMORDICA CHARANTIA EXTRACT.” 7(2827).
[16]. Suartha, I Nyoman, I Made Dira Swantara, and Wiwik Susanah Rita. 2016. “Ekstrak Etanol Dan Fraksi Heksan Buah Pare (Momordica Charantia) Sebagai Penurun Kadar Glukosa Darah Tikus Diabetes.” Jurnal Veteriner 17(1): 30–36.
[17]. Vitro, I N, Effect Of, Terpenoid Rich, and Extract Momordica. 2018. “IN VITRO EFFECT OF TERPENOIDS - RICH EXTRACT OF Momordica Charantia ON ALPHA GLUCOSIDASE ACTIVITY.” 25(3): 148–53.
[18]. Wan, Xiang et al. 2011. “Bioorganic & Medicinal Chemistry Dimerization of Piceatannol by Momordica Charantia Peroxidase and a -Glucosidase Inhibitory Activity of the Biotransformation Products.” Bioorganic & Medicinal Chemistry 19(17): 5085–92. http://dx.doi.org/10.1016/j.bmc.2011.07.032.
[19]. WHO. 2018. “World Health Organisation.” Global Report on Diabetes: 88.
[20]. Yuda I.K.A, Anthara M.S., Dharmayudha A.A.G.O. 2013. “Identifikasi Golongan Senyawa Kimia Estrak Etanol Buah Pare (Momordica Charantia) Dan Pengaruhnya Terhadap Penurunan Kadar Glukosa Darah Tikus Putih Jantan (Rattus Novergicus) Yang Diinduksi Aloksan.” Buletin Veteriner Udayana 5(2): 87–95.
[21]. Yue, Jiayin et al. 2017. “Cucurbitane Triterpenoids from Momordica Charantia L. and Their Inhibitory Activity against α-Glucosidase, α-Amylase and Protein Tyrosine Phosphatase 1B (PTP1B).” Journal of Functional Foods 37: 624–31. http://dx.doi.org/10.1016/j.jff.2017.07.041.
[22]. Zeng, Ke et al. 2014. “European Journal of Medicinal Chemistry New Compounds from Acid Hydrolyzed Products of the Fruits of Momordica Charantia L . and Their Inhibitory Activity against Protein Tyrosine Phosphatas 1B.” European Journal of Medicinal Chemistry 81: 176–80. http://dx.doi.org/10.1016/j.ejmech.2014.01.066.
